Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (282)
  2. Journal Article (128)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Correspondence (2)
  7. Conference Paper (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (438)
  2. Center for Hematologic Malignancies (438)
  3. Department of Medicine (438)
  4. Hematologic Malignancies, Division of (438)
  5. Survivorship Research (438)
  6. Myeloma (249)

More Groups

People
  1. Sergio Giralt (263)
  2. Hani Hassoun (224)
  3. David Chung (207)
  4. Alexander Lesokhin (187)
  5. Gunjan Shah (164)
  6. Sham Mailankody (147)

More People

Years
  1. 2025 (16)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (154)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (166)
  2. Elsevier Inc. (111)
  3. Nature Publishing Group (30)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (438)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival
    Meeting Abstract

    Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
    Blood (2008)

    Fulltext@MSK | Save
  • Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone
    Journal Article

    Lebovic, D.; Hoffman, J.; Levine, B. M.; Hassoun, H.; Landau, H.; Goldsmith, Y.; Maurer, M. S.; Steingart, R. M.; Cohen, A. D.; Comenzo, R. L.
    British Journal of Haematology (2008)

    Fulltext@MSK | Save
  • High dose chemotherapy and autologous stem cell transplantation with melphalan in patients with monoclonal immunoglobulin deposition disease associated with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Rafferty, B. T.; Flombaum, C.; D'Agati, V. D.; Klimek, V. M.; Cohen, A.; Boruchov, A.; Kewalramani, T.; Reich, L.; Landau, H.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • High leveI T cell suppression following purine analog therapy for patients with CLL correlates with important clinical benefit
    Meeting Abstract

    Landau, H.; Lamanna, N.; Hobart, S.; Weiss, M. A.
    Blood (2006)

    Fulltext@MSK | Save
  • AL amyloidosis in a patient with a T60A TTR mutation
    Meeting Abstract

    Landau, H.; Comenzo, R. L.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Wang, S.; Murphy, C. L.; Solomon, A.
    Amyloid (2006)

    Fulltext@MSK | Save
  • Richter's syndrome: Factors to predict response and survival
    Journal Article

    Landau, H.; Weiss, M.
    American Journal of Oncology Review (2006)

    Fulltext@MSK | Save
  • Clinical manifestations and treatment of newly diagnosed acute lymphoblastic leukemia in adults
    Journal Article

    Landau, H.; Lamanna, N.
    Current Hematologic Malignancy Reports (2006)

    Fulltext@MSK | Save